nodes	percent_of_prediction	percent_of_DWPC	metapath
Mometasone—NR3C1—hematologic cancer	0.129	1	CbGaD
Mometasone—Dexamethasone—hematologic cancer	0.0745	0.208	CrCtD
Mometasone—Betamethasone—hematologic cancer	0.0745	0.208	CrCtD
Mometasone—Triamcinolone—hematologic cancer	0.0728	0.203	CrCtD
Mometasone—Prednisone—hematologic cancer	0.0691	0.193	CrCtD
Mometasone—Prednisolone—hematologic cancer	0.0675	0.188	CrCtD
Mometasone—NR3C1—Triamcinolone—hematologic cancer	0.0246	0.173	CbGbCtD
Mometasone—NR3C1—Betamethasone—hematologic cancer	0.0211	0.149	CbGbCtD
Mometasone—NR3C1—Prednisolone—hematologic cancer	0.0208	0.147	CbGbCtD
Mometasone—NR3C1—Prednisone—hematologic cancer	0.0197	0.139	CbGbCtD
Mometasone—CYP2C8—Bortezomib—hematologic cancer	0.014	0.0988	CbGbCtD
Mometasone—NR3C1—Dexamethasone—hematologic cancer	0.0123	0.0865	CbGbCtD
Mometasone—CYP2C8—Ifosfamide—hematologic cancer	0.0107	0.0757	CbGbCtD
Mometasone—CYP2C8—Nilotinib—hematologic cancer	0.00933	0.0657	CbGbCtD
Mometasone—CYP2C8—Etoposide—hematologic cancer	0.00513	0.0362	CbGbCtD
Mometasone—CYP2C8—Dexamethasone—hematologic cancer	0.00422	0.0298	CbGbCtD
Mometasone—Fluticasone furoate—Dexamethasone—hematologic cancer	0.00251	0.00934	CrCrCtD
Mometasone—Fluticasone furoate—Betamethasone—hematologic cancer	0.00251	0.00934	CrCrCtD
Mometasone—Fluticasone furoate—Triamcinolone—hematologic cancer	0.00245	0.00913	CrCrCtD
Mometasone—Flumethasone Pivalate—Betamethasone—hematologic cancer	0.00225	0.0084	CrCrCtD
Mometasone—Flumethasone Pivalate—Dexamethasone—hematologic cancer	0.00225	0.0084	CrCrCtD
Mometasone—Flumethasone Pivalate—Triamcinolone—hematologic cancer	0.0022	0.0082	CrCrCtD
Mometasone—Fluticasone Propionate—Betamethasone—hematologic cancer	0.00218	0.00813	CrCrCtD
Mometasone—Halobetasol Propionate—Betamethasone—hematologic cancer	0.00218	0.00813	CrCrCtD
Mometasone—Difluprednate—Betamethasone—hematologic cancer	0.00218	0.00813	CrCrCtD
Mometasone—Difluprednate—Dexamethasone—hematologic cancer	0.00218	0.00813	CrCrCtD
Mometasone—Fluticasone Propionate—Dexamethasone—hematologic cancer	0.00218	0.00813	CrCrCtD
Mometasone—Halobetasol Propionate—Dexamethasone—hematologic cancer	0.00218	0.00813	CrCrCtD
Mometasone—Halobetasol Propionate—Triamcinolone—hematologic cancer	0.00213	0.00794	CrCrCtD
Mometasone—Fluticasone Propionate—Triamcinolone—hematologic cancer	0.00213	0.00794	CrCrCtD
Mometasone—Difluprednate—Triamcinolone—hematologic cancer	0.00213	0.00794	CrCrCtD
Mometasone—Prednicarbate—Betamethasone—hematologic cancer	0.00205	0.00764	CrCrCtD
Mometasone—Testolactone—Betamethasone—hematologic cancer	0.00205	0.00764	CrCrCtD
Mometasone—Prednicarbate—Dexamethasone—hematologic cancer	0.00205	0.00764	CrCrCtD
Mometasone—Fluocinonide—Betamethasone—hematologic cancer	0.00205	0.00764	CrCrCtD
Mometasone—Fluocinonide—Dexamethasone—hematologic cancer	0.00205	0.00764	CrCrCtD
Mometasone—Clocortolone—Betamethasone—hematologic cancer	0.00205	0.00764	CrCrCtD
Mometasone—Clocortolone—Dexamethasone—hematologic cancer	0.00205	0.00764	CrCrCtD
Mometasone—Beclomethasone—Betamethasone—hematologic cancer	0.00205	0.00764	CrCrCtD
Mometasone—Beclomethasone—Dexamethasone—hematologic cancer	0.00205	0.00764	CrCrCtD
Mometasone—Testolactone—Dexamethasone—hematologic cancer	0.00205	0.00764	CrCrCtD
Mometasone—Clocortolone—Triamcinolone—hematologic cancer	0.002	0.00747	CrCrCtD
Mometasone—Beclomethasone—Triamcinolone—hematologic cancer	0.002	0.00747	CrCrCtD
Mometasone—Fluocinonide—Triamcinolone—hematologic cancer	0.002	0.00747	CrCrCtD
Mometasone—Testolactone—Triamcinolone—hematologic cancer	0.002	0.00747	CrCrCtD
Mometasone—Prednicarbate—Triamcinolone—hematologic cancer	0.002	0.00747	CrCrCtD
Mometasone—Fluocortolone—Dexamethasone—hematologic cancer	0.00199	0.00742	CrCrCtD
Mometasone—Fluocortolone—Betamethasone—hematologic cancer	0.00199	0.00742	CrCrCtD
Mometasone—Fluocortolone—Triamcinolone—hematologic cancer	0.00195	0.00725	CrCrCtD
Mometasone—Alclometasone—Betamethasone—hematologic cancer	0.00194	0.00722	CrCrCtD
Mometasone—Fluocinolone Acetonide—Dexamethasone—hematologic cancer	0.00194	0.00722	CrCrCtD
Mometasone—Alclometasone—Dexamethasone—hematologic cancer	0.00194	0.00722	CrCrCtD
Mometasone—Fluocinolone Acetonide—Betamethasone—hematologic cancer	0.00194	0.00722	CrCrCtD
Mometasone—Prednicarbate—Prednisone—hematologic cancer	0.0019	0.00708	CrCrCtD
Mometasone—Testolactone—Prednisone—hematologic cancer	0.0019	0.00708	CrCrCtD
Mometasone—Alclometasone—Triamcinolone—hematologic cancer	0.00189	0.00705	CrCrCtD
Mometasone—Fluocinolone Acetonide—Triamcinolone—hematologic cancer	0.00189	0.00705	CrCrCtD
Mometasone—Budesonide—Betamethasone—hematologic cancer	0.00188	0.00702	CrCrCtD
Mometasone—Budesonide—Dexamethasone—hematologic cancer	0.00188	0.00702	CrCrCtD
Mometasone—Amcinonide—Dexamethasone—hematologic cancer	0.00188	0.00702	CrCrCtD
Mometasone—Amcinonide—Betamethasone—hematologic cancer	0.00188	0.00702	CrCrCtD
Mometasone—Fluoxymesterone—Betamethasone—hematologic cancer	0.00188	0.00702	CrCrCtD
Mometasone—Fluoxymesterone—Dexamethasone—hematologic cancer	0.00188	0.00702	CrCrCtD
Mometasone—Clocortolone—Prednisolone—hematologic cancer	0.00186	0.00692	CrCrCtD
Mometasone—Prednicarbate—Prednisolone—hematologic cancer	0.00186	0.00692	CrCrCtD
Mometasone—Testolactone—Prednisolone—hematologic cancer	0.00186	0.00692	CrCrCtD
Mometasone—Beclomethasone—Prednisolone—hematologic cancer	0.00186	0.00692	CrCrCtD
Mometasone—Fluocortolone—Prednisone—hematologic cancer	0.00185	0.00688	CrCrCtD
Mometasone—Budesonide—Triamcinolone—hematologic cancer	0.00184	0.00686	CrCrCtD
Mometasone—Fluoxymesterone—Triamcinolone—hematologic cancer	0.00184	0.00686	CrCrCtD
Mometasone—Amcinonide—Triamcinolone—hematologic cancer	0.00184	0.00686	CrCrCtD
Mometasone—Prednisone—Betamethasone—hematologic cancer	0.00184	0.00684	CrCrCtD
Mometasone—Diflorasone—Dexamethasone—hematologic cancer	0.00184	0.00684	CrCrCtD
Mometasone—Diflorasone—Betamethasone—hematologic cancer	0.00184	0.00684	CrCrCtD
Mometasone—Fludrocortisone—Dexamethasone—hematologic cancer	0.00184	0.00684	CrCrCtD
Mometasone—Flunisolide—Betamethasone—hematologic cancer	0.00184	0.00684	CrCrCtD
Mometasone—Fludrocortisone—Betamethasone—hematologic cancer	0.00184	0.00684	CrCrCtD
Mometasone—Flunisolide—Dexamethasone—hematologic cancer	0.00184	0.00684	CrCrCtD
Mometasone—Clobetasol propionate—Dexamethasone—hematologic cancer	0.00184	0.00684	CrCrCtD
Mometasone—Clobetasol propionate—Betamethasone—hematologic cancer	0.00184	0.00684	CrCrCtD
Mometasone—Desonide—Dexamethasone—hematologic cancer	0.00184	0.00684	CrCrCtD
Mometasone—Prednisone—Dexamethasone—hematologic cancer	0.00184	0.00684	CrCrCtD
Mometasone—Desonide—Betamethasone—hematologic cancer	0.00184	0.00684	CrCrCtD
Mometasone—Fluocortolone—Prednisolone—hematologic cancer	0.0018	0.00672	CrCrCtD
Mometasone—Alclometasone—Prednisone—hematologic cancer	0.0018	0.00669	CrCrCtD
Mometasone—Clobetasol propionate—Triamcinolone—hematologic cancer	0.00179	0.00668	CrCrCtD
Mometasone—Desonide—Triamcinolone—hematologic cancer	0.00179	0.00668	CrCrCtD
Mometasone—Prednisone—Triamcinolone—hematologic cancer	0.00179	0.00668	CrCrCtD
Mometasone—Diflorasone—Triamcinolone—hematologic cancer	0.00179	0.00668	CrCrCtD
Mometasone—Flunisolide—Triamcinolone—hematologic cancer	0.00179	0.00668	CrCrCtD
Mometasone—Fludrocortisone—Triamcinolone—hematologic cancer	0.00179	0.00668	CrCrCtD
Mometasone—Paramethasone—Betamethasone—hematologic cancer	0.00179	0.00667	CrCrCtD
Mometasone—Paramethasone—Dexamethasone—hematologic cancer	0.00179	0.00667	CrCrCtD
Mometasone—Fluocinolone Acetonide—Prednisolone—hematologic cancer	0.00175	0.00653	CrCrCtD
Mometasone—Alclometasone—Prednisolone—hematologic cancer	0.00175	0.00653	CrCrCtD
Mometasone—Paramethasone—Triamcinolone—hematologic cancer	0.00175	0.00652	CrCrCtD
Mometasone—Amcinonide—Prednisone—hematologic cancer	0.00175	0.00651	CrCrCtD
Mometasone—Budesonide—Prednisone—hematologic cancer	0.00175	0.00651	CrCrCtD
Mometasone—Desoximetasone—Dexamethasone—hematologic cancer	0.00175	0.00651	CrCrCtD
Mometasone—Desoximetasone—Betamethasone—hematologic cancer	0.00175	0.00651	CrCrCtD
Mometasone—Desoximetasone—Triamcinolone—hematologic cancer	0.00171	0.00636	CrCrCtD
Mometasone—Fluoxymesterone—Prednisolone—hematologic cancer	0.00171	0.00636	CrCrCtD
Mometasone—Amcinonide—Prednisolone—hematologic cancer	0.00171	0.00636	CrCrCtD
Mometasone—Budesonide—Prednisolone—hematologic cancer	0.00171	0.00636	CrCrCtD
Mometasone—Loteprednol—Dexamethasone—hematologic cancer	0.0017	0.00635	CrCrCtD
Mometasone—Loteprednol—Betamethasone—hematologic cancer	0.0017	0.00635	CrCrCtD
Mometasone—Fluprednidene Acetate—Betamethasone—hematologic cancer	0.0017	0.00635	CrCrCtD
Mometasone—Fluprednidene Acetate—Dexamethasone—hematologic cancer	0.0017	0.00635	CrCrCtD
Mometasone—Triamcinolone—Betamethasone—hematologic cancer	0.0017	0.00635	CrCrCtD
Mometasone—Triamcinolone—Dexamethasone—hematologic cancer	0.0017	0.00635	CrCrCtD
Mometasone—Fluorometholone—Betamethasone—hematologic cancer	0.0017	0.00635	CrCrCtD
Mometasone—Fluorometholone—Dexamethasone—hematologic cancer	0.0017	0.00635	CrCrCtD
Mometasone—Fludrocortisone—Prednisone—hematologic cancer	0.0017	0.00634	CrCrCtD
Mometasone—Flunisolide—Prednisone—hematologic cancer	0.0017	0.00634	CrCrCtD
Mometasone—Desonide—Prednisone—hematologic cancer	0.0017	0.00634	CrCrCtD
Mometasone—Diflorasone—Prednisone—hematologic cancer	0.0017	0.00634	CrCrCtD
Mometasone—Clobetasol propionate—Prednisone—hematologic cancer	0.0017	0.00634	CrCrCtD
Mometasone—Dexamethasone—Betamethasone—hematologic cancer	0.00167	0.00621	CrCrCtD
Mometasone—Rimexolone—Betamethasone—hematologic cancer	0.00167	0.00621	CrCrCtD
Mometasone—Rimexolone—Dexamethasone—hematologic cancer	0.00167	0.00621	CrCrCtD
Mometasone—Betamethasone—Dexamethasone—hematologic cancer	0.00167	0.00621	CrCrCtD
Mometasone—Fluorometholone—Triamcinolone—hematologic cancer	0.00167	0.00621	CrCrCtD
Mometasone—Fluprednidene Acetate—Triamcinolone—hematologic cancer	0.00167	0.00621	CrCrCtD
Mometasone—Loteprednol—Triamcinolone—hematologic cancer	0.00167	0.00621	CrCrCtD
Mometasone—Prednisone—Prednisolone—hematologic cancer	0.00166	0.00619	CrCrCtD
Mometasone—Clobetasol propionate—Prednisolone—hematologic cancer	0.00166	0.00619	CrCrCtD
Mometasone—Desonide—Prednisolone—hematologic cancer	0.00166	0.00619	CrCrCtD
Mometasone—Fludrocortisone—Prednisolone—hematologic cancer	0.00166	0.00619	CrCrCtD
Mometasone—Flunisolide—Prednisolone—hematologic cancer	0.00166	0.00619	CrCrCtD
Mometasone—Diflorasone—Prednisolone—hematologic cancer	0.00166	0.00619	CrCrCtD
Mometasone—Paramethasone—Prednisone—hematologic cancer	0.00166	0.00618	CrCrCtD
Mometasone—Dexamethasone—Triamcinolone—hematologic cancer	0.00163	0.00607	CrCrCtD
Mometasone—Rimexolone—Triamcinolone—hematologic cancer	0.00163	0.00607	CrCrCtD
Mometasone—Betamethasone—Triamcinolone—hematologic cancer	0.00163	0.00607	CrCrCtD
Mometasone—Paramethasone—Prednisolone—hematologic cancer	0.00162	0.00604	CrCrCtD
Mometasone—Desoximetasone—Prednisone—hematologic cancer	0.00162	0.00603	CrCrCtD
Mometasone—Methylprednisolone—Dexamethasone—hematologic cancer	0.00159	0.00594	CrCrCtD
Mometasone—Methylprednisolone—Betamethasone—hematologic cancer	0.00159	0.00594	CrCrCtD
Mometasone—Fluorometholone—Prednisone—hematologic cancer	0.00158	0.00589	CrCrCtD
Mometasone—Triamcinolone—Prednisone—hematologic cancer	0.00158	0.00589	CrCrCtD
Mometasone—Fluprednidene Acetate—Prednisone—hematologic cancer	0.00158	0.00589	CrCrCtD
Mometasone—Loteprednol—Prednisone—hematologic cancer	0.00158	0.00589	CrCrCtD
Mometasone—Desoximetasone—Prednisolone—hematologic cancer	0.00158	0.00589	CrCrCtD
Mometasone—Prednisolone—Betamethasone—hematologic cancer	0.00156	0.00581	CrCrCtD
Mometasone—Prednisolone—Dexamethasone—hematologic cancer	0.00156	0.00581	CrCrCtD
Mometasone—Methylprednisolone—Triamcinolone—hematologic cancer	0.00156	0.0058	CrCrCtD
Mometasone—Rimexolone—Prednisone—hematologic cancer	0.00154	0.00576	CrCrCtD
Mometasone—Betamethasone—Prednisone—hematologic cancer	0.00154	0.00576	CrCrCtD
Mometasone—Dexamethasone—Prednisone—hematologic cancer	0.00154	0.00576	CrCrCtD
Mometasone—Triamcinolone—Prednisolone—hematologic cancer	0.00154	0.00575	CrCrCtD
Mometasone—Fluprednidene Acetate—Prednisolone—hematologic cancer	0.00154	0.00575	CrCrCtD
Mometasone—Loteprednol—Prednisolone—hematologic cancer	0.00154	0.00575	CrCrCtD
Mometasone—Fluorometholone—Prednisolone—hematologic cancer	0.00154	0.00575	CrCrCtD
Mometasone—Prednisolone—Triamcinolone—hematologic cancer	0.00152	0.00568	CrCrCtD
Mometasone—Dexamethasone—Prednisolone—hematologic cancer	0.00151	0.00562	CrCrCtD
Mometasone—Rimexolone—Prednisolone—hematologic cancer	0.00151	0.00562	CrCrCtD
Mometasone—Betamethasone—Prednisolone—hematologic cancer	0.00151	0.00562	CrCrCtD
Mometasone—Hydrocortisone—Betamethasone—hematologic cancer	0.0015	0.00558	CrCrCtD
Mometasone—Hydrocortisone—Dexamethasone—hematologic cancer	0.0015	0.00558	CrCrCtD
Mometasone—Methylprednisolone—Prednisone—hematologic cancer	0.00148	0.00551	CrCrCtD
Mometasone—Hydrocortisone—Triamcinolone—hematologic cancer	0.00146	0.00545	CrCrCtD
Mometasone—Prednisolone—Prednisone—hematologic cancer	0.00145	0.00539	CrCrCtD
Mometasone—Methylprednisolone—Prednisolone—hematologic cancer	0.00144	0.00537	CrCrCtD
Mometasone—Hydrocortisone—Prednisone—hematologic cancer	0.00139	0.00517	CrCrCtD
Mometasone—Hydrocortisone—Prednisolone—hematologic cancer	0.00135	0.00505	CrCrCtD
Mometasone—Difluprednate—NR3C1—hematologic cancer	7.06e-05	0.0412	CrCbGaD
Mometasone—Clocortolone—NR3C1—hematologic cancer	6.84e-05	0.04	CrCbGaD
Mometasone—Prednicarbate—NR3C1—hematologic cancer	6.84e-05	0.04	CrCbGaD
Mometasone—Desonide—NR3C1—hematologic cancer	6.48e-05	0.0378	CrCbGaD
Mometasone—Diflorasone—NR3C1—hematologic cancer	6.48e-05	0.0378	CrCbGaD
Mometasone—Desoximetasone—NR3C1—hematologic cancer	6.32e-05	0.0369	CrCbGaD
Mometasone—Loteprednol—NR3C1—hematologic cancer	6.24e-05	0.0365	CrCbGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—HDAC2—hematologic cancer	6.19e-05	0.0032	CbGpPWpGaD
Mometasone—Fludrocortisone—AR—hematologic cancer	6.15e-05	0.036	CrCbGaD
Mometasone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CREBBP—hematologic cancer	6.1e-05	0.00315	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—HSP90AA1—hematologic cancer	5.75e-05	0.00297	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—RUNX3—hematologic cancer	5.68e-05	0.00293	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—STAT5B—hematologic cancer	5.67e-05	0.00293	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—STAT1—hematologic cancer	5.55e-05	0.00287	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—HDAC9—hematologic cancer	5.5e-05	0.00284	CbGpPWpGaD
Mometasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—CREB1—hematologic cancer	5.46e-05	0.00282	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—FOXM1—hematologic cancer	5.44e-05	0.00281	CbGpPWpGaD
Mometasone—Flumethasone Pivalate—NR3C1—hematologic cancer	5.44e-05	0.0318	CrCbGaD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AR—hematologic cancer	5.42e-05	0.0028	CbGpPWpGaD
Mometasone—NR3C1—Nuclear Receptor transcription pathway—ESR1—hematologic cancer	5.39e-05	0.00278	CbGpPWpGaD
Mometasone—Halobetasol Propionate—NR3C1—hematologic cancer	5.35e-05	0.0313	CrCbGaD
Mometasone—NR3C1—Regulation of Androgen receptor activity—MAPK14—hematologic cancer	5.33e-05	0.00275	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—IL10—hematologic cancer	5.32e-05	0.00275	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—CSF2—hematologic cancer	5.26e-05	0.00272	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—MYB—hematologic cancer	5.24e-05	0.00271	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—IL4—hematologic cancer	5.18e-05	0.00268	CbGpPWpGaD
Mometasone—NR3C1—Transcription factor regulation in adipogenesis—TNF—hematologic cancer	5.11e-05	0.00264	CbGpPWpGaD
Mometasone—Fluoxymesterone—AR—hematologic cancer	5.08e-05	0.0297	CrCbGaD
Mometasone—CYP2C8—Biological oxidations—SLC35B2—hematologic cancer	5.03e-05	0.0026	CbGpPWpGaD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—hematologic cancer	4.99e-05	0.00258	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—STAT5A—hematologic cancer	4.99e-05	0.00258	CbGpPWpGaD
Mometasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—hematologic cancer	4.97e-05	0.00257	CbGpPWpGaD
Mometasone—Amcinonide—NR3C1—hematologic cancer	4.97e-05	0.0291	CrCbGaD
Mometasone—Budesonide—NR3C1—hematologic cancer	4.97e-05	0.0291	CrCbGaD
Mometasone—CYP2C8—Metapathway biotransformation—EPHX1—hematologic cancer	4.96e-05	0.00256	CbGpPWpGaD
Mometasone—Fluticasone furoate—NR3C1—hematologic cancer	4.88e-05	0.0285	CrCbGaD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—hematologic cancer	4.74e-05	0.00245	CbGpPWpGaD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—NCOR1—hematologic cancer	4.74e-05	0.00245	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—HLA-A—hematologic cancer	4.69e-05	0.00242	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—GATA3—hematologic cancer	4.68e-05	0.00242	CbGpPWpGaD
Mometasone—Rimexolone—NR3C1—hematologic cancer	4.68e-05	0.0273	CrCbGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—CSF2—hematologic cancer	4.64e-05	0.0024	CbGpPWpGaD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOXO1—hematologic cancer	4.62e-05	0.00238	CbGpPWpGaD
Mometasone—NR3C1—Regulation of Androgen receptor activity—CREBBP—hematologic cancer	4.58e-05	0.00237	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—BAX—hematologic cancer	4.57e-05	0.00236	CbGpPWpGaD
Mometasone—NR3C1—Circadian Clock—CREB1—hematologic cancer	4.56e-05	0.00236	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—IL4—hematologic cancer	4.56e-05	0.00236	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—IL13—hematologic cancer	4.48e-05	0.00232	CbGpPWpGaD
Mometasone—NR3C1—Circadian Clock—CREBBP—hematologic cancer	4.45e-05	0.0023	CbGpPWpGaD
Mometasone—Fluocinonide—NR3C1—hematologic cancer	4.41e-05	0.0258	CrCbGaD
Mometasone—Beclomethasone—NR3C1—hematologic cancer	4.41e-05	0.0258	CrCbGaD
Mometasone—Fluocinolone Acetonide—NR3C1—hematologic cancer	4.29e-05	0.025	CrCbGaD
Mometasone—Alclometasone—NR3C1—hematologic cancer	4.29e-05	0.025	CrCbGaD
Mometasone—NR3C1—AP-1 transcription factor network—ESR1—hematologic cancer	4.18e-05	0.00216	CbGpPWpGaD
Mometasone—Clobetasol propionate—NR3C1—hematologic cancer	4.17e-05	0.0244	CrCbGaD
Mometasone—Flunisolide—NR3C1—hematologic cancer	4.17e-05	0.0244	CrCbGaD
Mometasone—Fludrocortisone—NR3C1—hematologic cancer	4.17e-05	0.0244	CrCbGaD
Mometasone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—hematologic cancer	4.16e-05	0.00215	CbGpPWpGaD
Mometasone—NR3C1—Endoderm Differentiation—NOTCH1—hematologic cancer	4.14e-05	0.00214	CbGpPWpGaD
Mometasone—NR3C1—Transcription factor regulation in adipogenesis—IL6—hematologic cancer	4.13e-05	0.00213	CbGpPWpGaD
Mometasone—Paramethasone—NR3C1—hematologic cancer	4.12e-05	0.0241	CrCbGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—GATA3—hematologic cancer	4.05e-05	0.00209	CbGpPWpGaD
Mometasone—Fluorometholone—NR3C1—hematologic cancer	4.02e-05	0.0235	CrCbGaD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK2—hematologic cancer	3.95e-05	0.00204	CbGpPWpGaD
Mometasone—Fluoxymesterone—ESR1—hematologic cancer	3.92e-05	0.0229	CrCbGaD
Mometasone—NR3C1—Regulation of Androgen receptor activity—MDM2—hematologic cancer	3.89e-05	0.00201	CbGpPWpGaD
Mometasone—Methylprednisolone—NR3C1—hematologic cancer	3.89e-05	0.0227	CrCbGaD
Mometasone—NR3C1—Adipogenesis—STAT1—hematologic cancer	3.84e-05	0.00198	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—FOS—hematologic cancer	3.77e-05	0.00195	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—CREB1—hematologic cancer	3.76e-05	0.00194	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—MAPK14—hematologic cancer	3.76e-05	0.00194	CbGpPWpGaD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK4—hematologic cancer	3.74e-05	0.00193	CbGpPWpGaD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—hematologic cancer	3.72e-05	0.00192	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—CCL2—hematologic cancer	3.68e-05	0.0019	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—ZNF552—hematologic cancer	3.67e-05	0.0019	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—hematologic cancer	3.63e-05	0.00187	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—STAT5A—hematologic cancer	3.45e-05	0.00178	CbGpPWpGaD
Mometasone—Fluoxymesterone—NR3C1—hematologic cancer	3.45e-05	0.0201	CrCbGaD
Mometasone—NR3C1—Regulation of Androgen receptor activity—JUN—hematologic cancer	3.38e-05	0.00175	CbGpPWpGaD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOS—hematologic cancer	3.35e-05	0.00173	CbGpPWpGaD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREB1—hematologic cancer	3.35e-05	0.00173	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—FOS—hematologic cancer	3.32e-05	0.00172	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—CREB1—hematologic cancer	3.32e-05	0.00171	CbGpPWpGaD
Mometasone—Triamcinolone—NR3C1—hematologic cancer	3.28e-05	0.0192	CrCbGaD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREBBP—hematologic cancer	3.26e-05	0.00168	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—NCOR1—hematologic cancer	3.24e-05	0.00168	CbGpPWpGaD
Mometasone—CYP2C8—Biological oxidations—GSTO1—hematologic cancer	3.24e-05	0.00167	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—CREBBP—hematologic cancer	3.23e-05	0.00167	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—CDKN2A—hematologic cancer	3.21e-05	0.00166	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—AR—hematologic cancer	3.21e-05	0.00166	CbGpPWpGaD
Mometasone—NR3C1—Regulation of Androgen receptor activity—MAPK8—hematologic cancer	3.2e-05	0.00165	CbGpPWpGaD
Mometasone—CYP2C8—Metapathway biotransformation—GSTO1—hematologic cancer	3.19e-05	0.00165	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—FOXO1—hematologic cancer	3.16e-05	0.00163	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—IFNG—hematologic cancer	3.13e-05	0.00162	CbGpPWpGaD
Mometasone—NR3C1—Regulation of Androgen receptor activity—EP300—hematologic cancer	3.12e-05	0.00161	CbGpPWpGaD
Mometasone—CYP2C8—Biological oxidations—UGT1A1—hematologic cancer	3.04e-05	0.00157	CbGpPWpGaD
Mometasone—NR3C1—Generic Transcription Pathway—RARA—hematologic cancer	3.03e-05	0.00157	CbGpPWpGaD
Mometasone—NR3C1—Regulation of Androgen receptor activity—SRC—hematologic cancer	3.03e-05	0.00157	CbGpPWpGaD
Mometasone—NR3C1—Circadian Clock—EP300—hematologic cancer	3.03e-05	0.00156	CbGpPWpGaD
Mometasone—CYP2C8—Metapathway biotransformation—UGT1A1—hematologic cancer	3e-05	0.00155	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—PHYH—hematologic cancer	2.99e-05	0.00155	CbGpPWpGaD
Mometasone—Prednisone—NR3C1—hematologic cancer	2.97e-05	0.0174	CrCbGaD
Mometasone—Fluticasone Propionate—NR3C1—hematologic cancer	2.93e-05	0.0171	CrCbGaD
Mometasone—NR3C1—Adipogenesis—FAS—hematologic cancer	2.91e-05	0.0015	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—CDKN1B—hematologic cancer	2.84e-05	0.00147	CbGpPWpGaD
Mometasone—NR3C1—Generic Transcription Pathway—NR0B2—hematologic cancer	2.82e-05	0.00146	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—HES1—hematologic cancer	2.82e-05	0.00146	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—IL10—hematologic cancer	2.8e-05	0.00145	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—IL2—hematologic cancer	2.78e-05	0.00144	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—CASC3—hematologic cancer	2.78e-05	0.00144	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—IFNG—hematologic cancer	2.76e-05	0.00143	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—MDM2—hematologic cancer	2.74e-05	0.00142	CbGpPWpGaD
Mometasone—Prednisolone—NR3C1—hematologic cancer	2.74e-05	0.016	CrCbGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—SMPD3—hematologic cancer	2.74e-05	0.00141	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—CCND1—hematologic cancer	2.71e-05	0.0014	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—JUN—hematologic cancer	2.71e-05	0.0014	CbGpPWpGaD
Mometasone—Betamethasone—NR3C1—hematologic cancer	2.69e-05	0.0157	CrCbGaD
Mometasone—CYP2C8—Biological oxidations—MTR—hematologic cancer	2.64e-05	0.00136	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—PTEN—hematologic cancer	2.62e-05	0.00135	CbGpPWpGaD
Mometasone—NR3C1—Generic Transcription Pathway—NCOR2—hematologic cancer	2.55e-05	0.00132	CbGpPWpGaD
Mometasone—CYP2C8—Biological oxidations—GSTT1—hematologic cancer	2.51e-05	0.0013	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—EP300—hematologic cancer	2.5e-05	0.00129	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—IL2—hematologic cancer	2.45e-05	0.00127	CbGpPWpGaD
Mometasone—Hydrocortisone—ABCG2—hematologic cancer	2.43e-05	0.0142	CrCbGaD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—hematologic cancer	2.41e-05	0.00124	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—JUN—hematologic cancer	2.38e-05	0.00123	CbGpPWpGaD
Mometasone—Fluticasone furoate—ABCB1—hematologic cancer	2.35e-05	0.0138	CrCbGaD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—hematologic cancer	2.33e-05	0.00121	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—hematologic cancer	2.31e-05	0.00119	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—CREB1—hematologic cancer	2.29e-05	0.00118	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—hematologic cancer	2.26e-05	0.00117	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—RB1—hematologic cancer	2.23e-05	0.00115	CbGpPWpGaD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—hematologic cancer	2.22e-05	0.00115	CbGpPWpGaD
Mometasone—NR3C1—Endoderm Differentiation—TGFB1—hematologic cancer	2.22e-05	0.00115	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—EP300—hematologic cancer	2.2e-05	0.00114	CbGpPWpGaD
Mometasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—hematologic cancer	2.19e-05	0.00113	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—MYC—hematologic cancer	2.18e-05	0.00112	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—TGFB1—hematologic cancer	2.17e-05	0.00112	CbGpPWpGaD
Mometasone—Hydrocortisone—NR3C1—hematologic cancer	2.1e-05	0.0122	CrCbGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—CREB1—hematologic cancer	1.98e-05	0.00102	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—hematologic cancer	1.97e-05	0.00102	CbGpPWpGaD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—hematologic cancer	1.94e-05	0.001	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—IL6R—hematologic cancer	1.93e-05	0.000999	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—CREBBP—hematologic cancer	1.93e-05	0.000997	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—GBA—hematologic cancer	1.93e-05	0.000997	CbGpPWpGaD
Mometasone—Methylprednisolone—ABCB1—hematologic cancer	1.88e-05	0.011	CrCbGaD
Mometasone—Dexamethasone—ABCG2—hematologic cancer	1.81e-05	0.0106	CrCbGaD
Mometasone—NR3C1—Gene Expression—RARS—hematologic cancer	1.79e-05	0.000926	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—TP53—hematologic cancer	1.79e-05	0.000923	CbGpPWpGaD
Mometasone—CYP2C8—Biological oxidations—GSTP1—hematologic cancer	1.74e-05	0.000899	CbGpPWpGaD
Mometasone—CYP2C8—Metapathway biotransformation—GSTP1—hematologic cancer	1.72e-05	0.000887	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—POLR3E—hematologic cancer	1.69e-05	0.000871	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—IL6—hematologic cancer	1.64e-05	0.000845	CbGpPWpGaD
Mometasone—NR3C1—Generic Transcription Pathway—PARP1—hematologic cancer	1.62e-05	0.000837	CbGpPWpGaD
Mometasone—CYP2C8—Biological oxidations—GSTM1—hematologic cancer	1.6e-05	0.000826	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—CDKN1A—hematologic cancer	1.6e-05	0.000826	CbGpPWpGaD
Mometasone—CYP2C8—Metapathway biotransformation—GSTM1—hematologic cancer	1.58e-05	0.000815	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—TP53—hematologic cancer	1.57e-05	0.000813	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—FHL2—hematologic cancer	1.57e-05	0.000813	CbGpPWpGaD
Mometasone—Dexamethasone—NR3C1—hematologic cancer	1.56e-05	0.00913	CrCbGaD
Mometasone—Asthenia—Mitoxantrone—hematologic cancer	1.55e-05	0.00019	CcSEcCtD
Mometasone—Asthenia—Irinotecan—hematologic cancer	1.55e-05	0.00019	CcSEcCtD
Mometasone—Fatigue—Etoposide—hematologic cancer	1.55e-05	0.00019	CcSEcCtD
Mometasone—Myalgia—Dexamethasone—hematologic cancer	1.54e-05	0.000189	CcSEcCtD
Mometasone—Myalgia—Betamethasone—hematologic cancer	1.54e-05	0.000189	CcSEcCtD
Mometasone—Vomiting—Thalidomide—hematologic cancer	1.54e-05	0.000189	CcSEcCtD
Mometasone—Pain—Etoposide—hematologic cancer	1.54e-05	0.000189	CcSEcCtD
Mometasone—Urinary tract infection—Epirubicin—hematologic cancer	1.53e-05	0.000188	CcSEcCtD
Mometasone—Conjunctivitis—Epirubicin—hematologic cancer	1.53e-05	0.000188	CcSEcCtD
Mometasone—Rash—Thalidomide—hematologic cancer	1.53e-05	0.000187	CcSEcCtD
Mometasone—Dermatitis—Thalidomide—hematologic cancer	1.52e-05	0.000187	CcSEcCtD
Mometasone—Upper respiratory tract infection—Doxorubicin—hematologic cancer	1.52e-05	0.000187	CcSEcCtD
Mometasone—Diarrhoea—Vincristine—hematologic cancer	1.52e-05	0.000186	CcSEcCtD
Mometasone—Headache—Thalidomide—hematologic cancer	1.52e-05	0.000186	CcSEcCtD
Mometasone—Pain—Prednisolone—hematologic cancer	1.52e-05	0.000186	CcSEcCtD
Mometasone—Asthenia—Gemcitabine—hematologic cancer	1.51e-05	0.000185	CcSEcCtD
Mometasone—Prednisone—ALB—hematologic cancer	1.5e-05	0.00879	CrCbGaD
Mometasone—Pharyngitis—Methotrexate—hematologic cancer	1.5e-05	0.000185	CcSEcCtD
Mometasone—Epistaxis—Epirubicin—hematologic cancer	1.49e-05	0.000183	CcSEcCtD
Mometasone—Pruritus—Gemcitabine—hematologic cancer	1.49e-05	0.000183	CcSEcCtD
Mometasone—Nausea—Thiotepa—hematologic cancer	1.49e-05	0.000182	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Triamcinolone—hematologic cancer	1.48e-05	0.000182	CcSEcCtD
Mometasone—Sinusitis—Epirubicin—hematologic cancer	1.48e-05	0.000182	CcSEcCtD
Mometasone—Anaphylactic shock—Dexamethasone—hematologic cancer	1.48e-05	0.000182	CcSEcCtD
Mometasone—Anaphylactic shock—Betamethasone—hematologic cancer	1.48e-05	0.000182	CcSEcCtD
Mometasone—Diarrhoea—Mitoxantrone—hematologic cancer	1.48e-05	0.000181	CcSEcCtD
Mometasone—Diarrhoea—Irinotecan—hematologic cancer	1.48e-05	0.000181	CcSEcCtD
Mometasone—Vomiting—Carmustine—hematologic cancer	1.48e-05	0.000181	CcSEcCtD
Mometasone—NR3C1—SIDS Susceptibility Pathways—IL1B—hematologic cancer	1.47e-05	0.00076	CbGpPWpGaD
Mometasone—Gastrointestinal pain—Etoposide—hematologic cancer	1.47e-05	0.00018	CcSEcCtD
Mometasone—Infection—Dexamethasone—hematologic cancer	1.47e-05	0.00018	CcSEcCtD
Mometasone—Infection—Betamethasone—hematologic cancer	1.47e-05	0.00018	CcSEcCtD
Mometasone—NR3C1—SIDS Susceptibility Pathways—CASP3—hematologic cancer	1.47e-05	0.000758	CbGpPWpGaD
Mometasone—Rash—Carmustine—hematologic cancer	1.46e-05	0.00018	CcSEcCtD
Mometasone—Dermatitis—Carmustine—hematologic cancer	1.46e-05	0.00018	CcSEcCtD
Mometasone—Vomiting—Alitretinoin—hematologic cancer	1.46e-05	0.00018	CcSEcCtD
Mometasone—Paraesthesia—Triamcinolone—hematologic cancer	1.46e-05	0.00018	CcSEcCtD
Mometasone—NR3C1—Gene Expression—RARA—hematologic cancer	1.46e-05	0.000755	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—TET2—hematologic cancer	1.46e-05	0.000755	CbGpPWpGaD
Mometasone—Headache—Carmustine—hematologic cancer	1.46e-05	0.000179	CcSEcCtD
Mometasone—Dyspnoea—Triamcinolone—hematologic cancer	1.45e-05	0.000178	CcSEcCtD
Mometasone—Rash—Alitretinoin—hematologic cancer	1.45e-05	0.000178	CcSEcCtD
Mometasone—Dermatitis—Alitretinoin—hematologic cancer	1.45e-05	0.000178	CcSEcCtD
Mometasone—Vomiting—Ifosfamide—hematologic cancer	1.45e-05	0.000178	CcSEcCtD
Mometasone—Headache—Alitretinoin—hematologic cancer	1.44e-05	0.000177	CcSEcCtD
Mometasone—Angioedema—Prednisone—hematologic cancer	1.44e-05	0.000177	CcSEcCtD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—IL6—hematologic cancer	1.44e-05	0.000744	CbGpPWpGaD
Mometasone—Diarrhoea—Gemcitabine—hematologic cancer	1.44e-05	0.000177	CcSEcCtD
Mometasone—Nausea—Thalidomide—hematologic cancer	1.44e-05	0.000176	CcSEcCtD
Mometasone—Prednisone—ABCB1—hematologic cancer	1.43e-05	0.00838	CrCbGaD
Mometasone—Dyspepsia—Triamcinolone—hematologic cancer	1.43e-05	0.000176	CcSEcCtD
Mometasone—Rash—Ifosfamide—hematologic cancer	1.43e-05	0.000176	CcSEcCtD
Mometasone—NR3C1—Gene Expression—RPLP1—hematologic cancer	1.43e-05	0.00074	CbGpPWpGaD
Mometasone—Dermatitis—Ifosfamide—hematologic cancer	1.43e-05	0.000176	CcSEcCtD
Mometasone—NR3C1—Adipogenesis—STAT3—hematologic cancer	1.43e-05	0.000737	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—JUN—hematologic cancer	1.43e-05	0.000736	CbGpPWpGaD
Mometasone—Rhinitis—Epirubicin—hematologic cancer	1.42e-05	0.000174	CcSEcCtD
Mometasone—Body temperature increased—Etoposide—hematologic cancer	1.42e-05	0.000174	CcSEcCtD
Mometasone—Abdominal pain—Etoposide—hematologic cancer	1.42e-05	0.000174	CcSEcCtD
Mometasone—Urinary tract infection—Doxorubicin—hematologic cancer	1.42e-05	0.000174	CcSEcCtD
Mometasone—Conjunctivitis—Doxorubicin—hematologic cancer	1.42e-05	0.000174	CcSEcCtD
Mometasone—Vomiting—Vincristine—hematologic cancer	1.41e-05	0.000173	CcSEcCtD
Mometasone—Anorexia—Betamethasone—hematologic cancer	1.41e-05	0.000173	CcSEcCtD
Mometasone—Anorexia—Dexamethasone—hematologic cancer	1.41e-05	0.000173	CcSEcCtD
Mometasone—Asthenia—Cisplatin—hematologic cancer	1.41e-05	0.000173	CcSEcCtD
Mometasone—Pharyngitis—Epirubicin—hematologic cancer	1.41e-05	0.000173	CcSEcCtD
Mometasone—Fatigue—Triamcinolone—hematologic cancer	1.4e-05	0.000172	CcSEcCtD
Mometasone—Rash—Vincristine—hematologic cancer	1.4e-05	0.000172	CcSEcCtD
Mometasone—Dermatitis—Vincristine—hematologic cancer	1.4e-05	0.000172	CcSEcCtD
Mometasone—Pain—Triamcinolone—hematologic cancer	1.39e-05	0.000171	CcSEcCtD
Mometasone—Headache—Vincristine—hematologic cancer	1.39e-05	0.000171	CcSEcCtD
Mometasone—Nausea—Carmustine—hematologic cancer	1.38e-05	0.000169	CcSEcCtD
Mometasone—Epistaxis—Doxorubicin—hematologic cancer	1.38e-05	0.000169	CcSEcCtD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—ARNTL—hematologic cancer	1.37e-05	0.00071	CbGpPWpGaD
Mometasone—Vomiting—Mitoxantrone—hematologic cancer	1.37e-05	0.000169	CcSEcCtD
Mometasone—Vomiting—Irinotecan—hematologic cancer	1.37e-05	0.000169	CcSEcCtD
Mometasone—Sinusitis—Doxorubicin—hematologic cancer	1.37e-05	0.000168	CcSEcCtD
Mometasone—Immune system disorder—Methotrexate—hematologic cancer	1.37e-05	0.000168	CcSEcCtD
Mometasone—Nausea—Alitretinoin—hematologic cancer	1.37e-05	0.000168	CcSEcCtD
Mometasone—Mediastinal disorder—Methotrexate—hematologic cancer	1.36e-05	0.000168	CcSEcCtD
Mometasone—Rash—Irinotecan—hematologic cancer	1.36e-05	0.000167	CcSEcCtD
Mometasone—Rash—Mitoxantrone—hematologic cancer	1.36e-05	0.000167	CcSEcCtD
Mometasone—Dermatitis—Mitoxantrone—hematologic cancer	1.36e-05	0.000167	CcSEcCtD
Mometasone—Dermatitis—Irinotecan—hematologic cancer	1.36e-05	0.000167	CcSEcCtD
Mometasone—NR3C1—Gene Expression—NR0B2—hematologic cancer	1.36e-05	0.000702	CbGpPWpGaD
Mometasone—NR3C1—Generic Transcription Pathway—AR—hematologic cancer	1.36e-05	0.0007	CbGpPWpGaD
Mometasone—Headache—Mitoxantrone—hematologic cancer	1.35e-05	0.000166	CcSEcCtD
Mometasone—Headache—Irinotecan—hematologic cancer	1.35e-05	0.000166	CcSEcCtD
Mometasone—Nausea—Ifosfamide—hematologic cancer	1.35e-05	0.000166	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Betamethasone—hematologic cancer	1.35e-05	0.000165	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	1.35e-05	0.000165	CcSEcCtD
Mometasone—Arthralgia—Prednisone—hematologic cancer	1.34e-05	0.000165	CcSEcCtD
Mometasone—Myalgia—Prednisone—hematologic cancer	1.34e-05	0.000165	CcSEcCtD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—hematologic cancer	1.34e-05	0.000693	CbGpPWpGaD
Mometasone—Diarrhoea—Cisplatin—hematologic cancer	1.34e-05	0.000165	CcSEcCtD
Mometasone—Vomiting—Gemcitabine—hematologic cancer	1.34e-05	0.000164	CcSEcCtD
Mometasone—CYP2C8—Metabolism—PHYH—hematologic cancer	1.33e-05	0.000689	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GMPS—hematologic cancer	1.33e-05	0.000689	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—FTCD—hematologic cancer	1.33e-05	0.000689	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—hematologic cancer	1.33e-05	0.000687	CbGpPWpGaD
Mometasone—Paraesthesia—Betamethasone—hematologic cancer	1.33e-05	0.000163	CcSEcCtD
Mometasone—Paraesthesia—Dexamethasone—hematologic cancer	1.33e-05	0.000163	CcSEcCtD
Mometasone—Rash—Gemcitabine—hematologic cancer	1.33e-05	0.000163	CcSEcCtD
Mometasone—Dermatitis—Gemcitabine—hematologic cancer	1.33e-05	0.000163	CcSEcCtD
Mometasone—Prednisolone—ABCB1—hematologic cancer	1.32e-05	0.00773	CrCbGaD
Mometasone—NR3C1—Adipogenesis—TGFB1—hematologic cancer	1.32e-05	0.000683	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—NCOR2—hematologic cancer	1.32e-05	0.000682	CbGpPWpGaD
Mometasone—Headache—Gemcitabine—hematologic cancer	1.32e-05	0.000162	CcSEcCtD
Mometasone—Nausea—Vincristine—hematologic cancer	1.32e-05	0.000162	CcSEcCtD
Mometasone—NR3C1—SIDS Susceptibility Pathways—EP300—hematologic cancer	1.31e-05	0.000679	CbGpPWpGaD
Mometasone—Rhinitis—Doxorubicin—hematologic cancer	1.31e-05	0.000161	CcSEcCtD
Mometasone—Pharyngitis—Doxorubicin—hematologic cancer	1.3e-05	0.00016	CcSEcCtD
Mometasone—Dyspepsia—Betamethasone—hematologic cancer	1.3e-05	0.00016	CcSEcCtD
Mometasone—Dyspepsia—Dexamethasone—hematologic cancer	1.3e-05	0.00016	CcSEcCtD
Mometasone—Betamethasone—ABCB1—hematologic cancer	1.3e-05	0.00757	CrCbGaD
Mometasone—NR3C1—Gene Expression—DNMT3A—hematologic cancer	1.3e-05	0.000669	CbGpPWpGaD
Mometasone—Asthenia—Etoposide—hematologic cancer	1.29e-05	0.000158	CcSEcCtD
Mometasone—Body temperature increased—Triamcinolone—hematologic cancer	1.29e-05	0.000158	CcSEcCtD
Mometasone—Anaphylactic shock—Prednisone—hematologic cancer	1.29e-05	0.000158	CcSEcCtD
Mometasone—Decreased appetite—Betamethasone—hematologic cancer	1.29e-05	0.000158	CcSEcCtD
Mometasone—Decreased appetite—Dexamethasone—hematologic cancer	1.29e-05	0.000158	CcSEcCtD
Mometasone—Nausea—Irinotecan—hematologic cancer	1.28e-05	0.000158	CcSEcCtD
Mometasone—Nausea—Mitoxantrone—hematologic cancer	1.28e-05	0.000158	CcSEcCtD
Mometasone—Immune system disorder—Epirubicin—hematologic cancer	1.28e-05	0.000157	CcSEcCtD
Mometasone—Infection—Prednisone—hematologic cancer	1.28e-05	0.000157	CcSEcCtD
Mometasone—Mediastinal disorder—Epirubicin—hematologic cancer	1.28e-05	0.000157	CcSEcCtD
Mometasone—NR3C1—Gene Expression—ELL—hematologic cancer	1.28e-05	0.00066	CbGpPWpGaD
Mometasone—Back pain—Methotrexate—hematologic cancer	1.28e-05	0.000157	CcSEcCtD
Mometasone—Fatigue—Dexamethasone—hematologic cancer	1.27e-05	0.000157	CcSEcCtD
Mometasone—Fatigue—Betamethasone—hematologic cancer	1.27e-05	0.000157	CcSEcCtD
Mometasone—Pruritus—Etoposide—hematologic cancer	1.27e-05	0.000156	CcSEcCtD
Mometasone—Pain—Dexamethasone—hematologic cancer	1.26e-05	0.000155	CcSEcCtD
Mometasone—Pain—Betamethasone—hematologic cancer	1.26e-05	0.000155	CcSEcCtD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—hematologic cancer	1.26e-05	0.00065	CbGpPWpGaD
Mometasone—Nausea—Gemcitabine—hematologic cancer	1.25e-05	0.000153	CcSEcCtD
Mometasone—NR3C1—Generic Transcription Pathway—CDKN2B—hematologic cancer	1.25e-05	0.000645	CbGpPWpGaD
Mometasone—Vomiting—Cisplatin—hematologic cancer	1.25e-05	0.000153	CcSEcCtD
Mometasone—NR3C1—SIDS Susceptibility Pathways—VEGFA—hematologic cancer	1.25e-05	0.000643	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—ABCC3—hematologic cancer	1.24e-05	0.000642	CbGpPWpGaD
Mometasone—Rash—Cisplatin—hematologic cancer	1.24e-05	0.000152	CcSEcCtD
Mometasone—Dermatitis—Cisplatin—hematologic cancer	1.24e-05	0.000152	CcSEcCtD
Mometasone—NR3C1—Adipogenesis—TNF—hematologic cancer	1.23e-05	0.000638	CbGpPWpGaD
Mometasone—Diarrhoea—Etoposide—hematologic cancer	1.23e-05	0.000151	CcSEcCtD
Mometasone—Anorexia—Prednisone—hematologic cancer	1.23e-05	0.000151	CcSEcCtD
Mometasone—NR3C1—Gene Expression—NCOR2—hematologic cancer	1.23e-05	0.000633	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—SMPD3—hematologic cancer	1.22e-05	0.00063	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	1.22e-05	0.000629	CbGpPWpGaD
Mometasone—Gastrointestinal pain—Dexamethasone—hematologic cancer	1.21e-05	0.000148	CcSEcCtD
Mometasone—Gastrointestinal pain—Betamethasone—hematologic cancer	1.21e-05	0.000148	CcSEcCtD
Mometasone—Back pain—Epirubicin—hematologic cancer	1.19e-05	0.000147	CcSEcCtD
Mometasone—NR3C1—Generic Transcription Pathway—NCOR1—hematologic cancer	1.18e-05	0.000612	CbGpPWpGaD
Mometasone—Immune system disorder—Doxorubicin—hematologic cancer	1.18e-05	0.000145	CcSEcCtD
Mometasone—Mediastinal disorder—Doxorubicin—hematologic cancer	1.18e-05	0.000145	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Prednisone—hematologic cancer	1.17e-05	0.000144	CcSEcCtD
Mometasone—Asthenia—Triamcinolone—hematologic cancer	1.17e-05	0.000144	CcSEcCtD
Mometasone—Abdominal pain—Betamethasone—hematologic cancer	1.17e-05	0.000144	CcSEcCtD
Mometasone—Abdominal pain—Dexamethasone—hematologic cancer	1.17e-05	0.000144	CcSEcCtD
Mometasone—Body temperature increased—Dexamethasone—hematologic cancer	1.17e-05	0.000144	CcSEcCtD
Mometasone—Body temperature increased—Betamethasone—hematologic cancer	1.17e-05	0.000144	CcSEcCtD
Mometasone—Nausea—Cisplatin—hematologic cancer	1.16e-05	0.000143	CcSEcCtD
Mometasone—Paraesthesia—Prednisone—hematologic cancer	1.16e-05	0.000142	CcSEcCtD
Mometasone—Pruritus—Triamcinolone—hematologic cancer	1.15e-05	0.000142	CcSEcCtD
Mometasone—Cough—Methotrexate—hematologic cancer	1.15e-05	0.000141	CcSEcCtD
Mometasone—Vomiting—Etoposide—hematologic cancer	1.14e-05	0.00014	CcSEcCtD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	1.14e-05	0.000588	CbGpPWpGaD
Mometasone—Dyspepsia—Prednisone—hematologic cancer	1.13e-05	0.000139	CcSEcCtD
Mometasone—Rash—Etoposide—hematologic cancer	1.13e-05	0.000139	CcSEcCtD
Mometasone—Dermatitis—Etoposide—hematologic cancer	1.13e-05	0.000139	CcSEcCtD
Mometasone—NR3C1—Gene Expression—AGO2—hematologic cancer	1.13e-05	0.000584	CbGpPWpGaD
Mometasone—Headache—Etoposide—hematologic cancer	1.13e-05	0.000138	CcSEcCtD
Mometasone—Arthralgia—Methotrexate—hematologic cancer	1.12e-05	0.000138	CcSEcCtD
Mometasone—Chest pain—Methotrexate—hematologic cancer	1.12e-05	0.000138	CcSEcCtD
Mometasone—Myalgia—Methotrexate—hematologic cancer	1.12e-05	0.000138	CcSEcCtD
Mometasone—Decreased appetite—Prednisone—hematologic cancer	1.12e-05	0.000137	CcSEcCtD
Mometasone—Rash—Prednisolone—hematologic cancer	1.12e-05	0.000137	CcSEcCtD
Mometasone—Dermatitis—Prednisolone—hematologic cancer	1.12e-05	0.000137	CcSEcCtD
Mometasone—Fatigue—Prednisone—hematologic cancer	1.11e-05	0.000136	CcSEcCtD
Mometasone—Headache—Prednisolone—hematologic cancer	1.11e-05	0.000136	CcSEcCtD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	1.11e-05	0.000573	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—DNMT3B—hematologic cancer	1.11e-05	0.000572	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—H3F3B—hematologic cancer	1.11e-05	0.000572	CbGpPWpGaD
Mometasone—Back pain—Doxorubicin—hematologic cancer	1.1e-05	0.000136	CcSEcCtD
Mometasone—Cough—Epirubicin—hematologic cancer	1.08e-05	0.000132	CcSEcCtD
Mometasone—Anaphylactic shock—Methotrexate—hematologic cancer	1.08e-05	0.000132	CcSEcCtD
Mometasone—Infection—Methotrexate—hematologic cancer	1.07e-05	0.000131	CcSEcCtD
Mometasone—NR3C1—SIDS Susceptibility Pathways—TNF—hematologic cancer	1.07e-05	0.000551	CbGpPWpGaD
Mometasone—Nausea—Etoposide—hematologic cancer	1.07e-05	0.000131	CcSEcCtD
Mometasone—CYP2C8—Metabolism—DCK—hematologic cancer	1.07e-05	0.000551	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ASNS—hematologic cancer	1.07e-05	0.000551	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—B3GAT1—hematologic cancer	1.07e-05	0.000551	CbGpPWpGaD
Mometasone—Asthenia—Dexamethasone—hematologic cancer	1.06e-05	0.00013	CcSEcCtD
Mometasone—Asthenia—Betamethasone—hematologic cancer	1.06e-05	0.00013	CcSEcCtD
Mometasone—Gastrointestinal pain—Prednisone—hematologic cancer	1.05e-05	0.000129	CcSEcCtD
Mometasone—Nausea—Prednisolone—hematologic cancer	1.05e-05	0.000129	CcSEcCtD
Mometasone—Myalgia—Epirubicin—hematologic cancer	1.05e-05	0.000129	CcSEcCtD
Mometasone—Chest pain—Epirubicin—hematologic cancer	1.05e-05	0.000129	CcSEcCtD
Mometasone—Arthralgia—Epirubicin—hematologic cancer	1.05e-05	0.000129	CcSEcCtD
Mometasone—Pruritus—Betamethasone—hematologic cancer	1.05e-05	0.000128	CcSEcCtD
Mometasone—Pruritus—Dexamethasone—hematologic cancer	1.05e-05	0.000128	CcSEcCtD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	1.04e-05	0.000538	CbGpPWpGaD
Mometasone—Vomiting—Triamcinolone—hematologic cancer	1.04e-05	0.000127	CcSEcCtD
Mometasone—Rash—Triamcinolone—hematologic cancer	1.03e-05	0.000126	CcSEcCtD
Mometasone—Dry mouth—Epirubicin—hematologic cancer	1.03e-05	0.000126	CcSEcCtD
Mometasone—Dermatitis—Triamcinolone—hematologic cancer	1.03e-05	0.000126	CcSEcCtD
Mometasone—Anorexia—Methotrexate—hematologic cancer	1.03e-05	0.000126	CcSEcCtD
Mometasone—Headache—Triamcinolone—hematologic cancer	1.02e-05	0.000125	CcSEcCtD
Mometasone—Abdominal pain—Prednisone—hematologic cancer	1.02e-05	0.000125	CcSEcCtD
Mometasone—Body temperature increased—Prednisone—hematologic cancer	1.02e-05	0.000125	CcSEcCtD
Mometasone—NR3C1—Gene Expression—RPS14—hematologic cancer	1.01e-05	0.000523	CbGpPWpGaD
Mometasone—Hydrocortisone—ABCB1—hematologic cancer	1.01e-05	0.00591	CrCbGaD
Mometasone—Diarrhoea—Betamethasone—hematologic cancer	1.01e-05	0.000124	CcSEcCtD
Mometasone—Diarrhoea—Dexamethasone—hematologic cancer	1.01e-05	0.000124	CcSEcCtD
Mometasone—CYP2C8—Metabolism—HDC—hematologic cancer	1.01e-05	0.000522	CbGpPWpGaD
Mometasone—Anaphylactic shock—Epirubicin—hematologic cancer	1.01e-05	0.000124	CcSEcCtD
Mometasone—Infection—Epirubicin—hematologic cancer	1e-05	0.000123	CcSEcCtD
Mometasone—NR3C1—Gene Expression—NUP98—hematologic cancer	9.97e-06	0.000515	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—IL6—hematologic cancer	9.97e-06	0.000515	CbGpPWpGaD
Mometasone—Cough—Doxorubicin—hematologic cancer	9.96e-06	0.000122	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Methotrexate—hematologic cancer	9.8e-06	0.00012	CcSEcCtD
Mometasone—Myalgia—Doxorubicin—hematologic cancer	9.72e-06	0.000119	CcSEcCtD
Mometasone—Chest pain—Doxorubicin—hematologic cancer	9.72e-06	0.000119	CcSEcCtD
Mometasone—Arthralgia—Doxorubicin—hematologic cancer	9.72e-06	0.000119	CcSEcCtD
Mometasone—Nausea—Triamcinolone—hematologic cancer	9.68e-06	0.000119	CcSEcCtD
Mometasone—Paraesthesia—Methotrexate—hematologic cancer	9.66e-06	0.000119	CcSEcCtD
Mometasone—NR3C1—Gene Expression—NUP214—hematologic cancer	9.61e-06	0.000496	CbGpPWpGaD
Mometasone—Anorexia—Epirubicin—hematologic cancer	9.6e-06	0.000118	CcSEcCtD
Mometasone—Dyspnoea—Methotrexate—hematologic cancer	9.59e-06	0.000118	CcSEcCtD
Mometasone—Dry mouth—Doxorubicin—hematologic cancer	9.51e-06	0.000117	CcSEcCtD
Mometasone—Dyspepsia—Methotrexate—hematologic cancer	9.47e-06	0.000116	CcSEcCtD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	9.42e-06	0.000487	CbGpPWpGaD
Mometasone—Vomiting—Betamethasone—hematologic cancer	9.4e-06	0.000115	CcSEcCtD
Mometasone—Vomiting—Dexamethasone—hematologic cancer	9.4e-06	0.000115	CcSEcCtD
Mometasone—Decreased appetite—Methotrexate—hematologic cancer	9.35e-06	0.000115	CcSEcCtD
Mometasone—Rash—Betamethasone—hematologic cancer	9.32e-06	0.000114	CcSEcCtD
Mometasone—Rash—Dexamethasone—hematologic cancer	9.32e-06	0.000114	CcSEcCtD
Mometasone—Anaphylactic shock—Doxorubicin—hematologic cancer	9.32e-06	0.000114	CcSEcCtD
Mometasone—Dermatitis—Dexamethasone—hematologic cancer	9.31e-06	0.000114	CcSEcCtD
Mometasone—Dermatitis—Betamethasone—hematologic cancer	9.31e-06	0.000114	CcSEcCtD
Mometasone—NR3C1—Generic Transcription Pathway—ESR1—hematologic cancer	9.31e-06	0.000481	CbGpPWpGaD
Mometasone—Fatigue—Methotrexate—hematologic cancer	9.28e-06	0.000114	CcSEcCtD
Mometasone—Headache—Dexamethasone—hematologic cancer	9.26e-06	0.000114	CcSEcCtD
Mometasone—Headache—Betamethasone—hematologic cancer	9.26e-06	0.000114	CcSEcCtD
Mometasone—Infection—Doxorubicin—hematologic cancer	9.26e-06	0.000114	CcSEcCtD
Mometasone—CYP2C8—Metabolism—CDA—hematologic cancer	9.24e-06	0.000478	CbGpPWpGaD
Mometasone—Asthenia—Prednisone—hematologic cancer	9.24e-06	0.000113	CcSEcCtD
Mometasone—Pain—Methotrexate—hematologic cancer	9.2e-06	0.000113	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Epirubicin—hematologic cancer	9.17e-06	0.000113	CcSEcCtD
Mometasone—Pruritus—Prednisone—hematologic cancer	9.11e-06	0.000112	CcSEcCtD
Mometasone—Paraesthesia—Epirubicin—hematologic cancer	9.04e-06	0.000111	CcSEcCtD
Mometasone—NR3C1—Generic Transcription Pathway—NOTCH1—hematologic cancer	9e-06	0.000465	CbGpPWpGaD
Mometasone—Dyspnoea—Epirubicin—hematologic cancer	8.98e-06	0.00011	CcSEcCtD
Mometasone—CYP2C8—Metabolism—PC—hematologic cancer	8.9e-06	0.00046	CbGpPWpGaD
Mometasone—Anorexia—Doxorubicin—hematologic cancer	8.88e-06	0.000109	CcSEcCtD
Mometasone—Dyspepsia—Epirubicin—hematologic cancer	8.86e-06	0.000109	CcSEcCtD
Mometasone—NR3C1—Gene Expression—EIF4EBP1—hematologic cancer	8.85e-06	0.000457	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—HSPB1—hematologic cancer	8.85e-06	0.000457	CbGpPWpGaD
Mometasone—Diarrhoea—Prednisone—hematologic cancer	8.81e-06	0.000108	CcSEcCtD
Mometasone—Gastrointestinal pain—Methotrexate—hematologic cancer	8.8e-06	0.000108	CcSEcCtD
Mometasone—Nausea—Dexamethasone—hematologic cancer	8.78e-06	0.000108	CcSEcCtD
Mometasone—Nausea—Betamethasone—hematologic cancer	8.78e-06	0.000108	CcSEcCtD
Mometasone—Decreased appetite—Epirubicin—hematologic cancer	8.75e-06	0.000107	CcSEcCtD
Mometasone—Fatigue—Epirubicin—hematologic cancer	8.68e-06	0.000107	CcSEcCtD
Mometasone—NR3C1—SIDS Susceptibility Pathways—IL6—hematologic cancer	8.61e-06	0.000445	CbGpPWpGaD
Mometasone—Pain—Epirubicin—hematologic cancer	8.61e-06	0.000106	CcSEcCtD
Mometasone—CYP2C8—Metabolism—GBA—hematologic cancer	8.59e-06	0.000444	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—SLC35B2—hematologic cancer	8.59e-06	0.000444	CbGpPWpGaD
Mometasone—Body temperature increased—Methotrexate—hematologic cancer	8.51e-06	0.000104	CcSEcCtD
Mometasone—Abdominal pain—Methotrexate—hematologic cancer	8.51e-06	0.000104	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	8.49e-06	0.000104	CcSEcCtD
Mometasone—NR3C1—Gene Expression—SMC1A—hematologic cancer	8.48e-06	0.000438	CbGpPWpGaD
Mometasone—Paraesthesia—Doxorubicin—hematologic cancer	8.37e-06	0.000103	CcSEcCtD
Mometasone—NR3C1—Gene Expression—H3F3A—hematologic cancer	8.31e-06	0.000429	CbGpPWpGaD
Mometasone—Dyspnoea—Doxorubicin—hematologic cancer	8.31e-06	0.000102	CcSEcCtD
Mometasone—Gastrointestinal pain—Epirubicin—hematologic cancer	8.23e-06	0.000101	CcSEcCtD
Mometasone—Dyspepsia—Doxorubicin—hematologic cancer	8.2e-06	0.000101	CcSEcCtD
Mometasone—Vomiting—Prednisone—hematologic cancer	8.19e-06	0.000101	CcSEcCtD
Mometasone—NR3C1—Generic Transcription Pathway—CREBBP—hematologic cancer	8.16e-06	0.000421	CbGpPWpGaD
Mometasone—Rash—Prednisone—hematologic cancer	8.12e-06	9.97e-05	CcSEcCtD
Mometasone—Dermatitis—Prednisone—hematologic cancer	8.11e-06	9.96e-05	CcSEcCtD
Mometasone—Decreased appetite—Doxorubicin—hematologic cancer	8.1e-06	9.95e-05	CcSEcCtD
Mometasone—Headache—Prednisone—hematologic cancer	8.07e-06	9.9e-05	CcSEcCtD
Mometasone—Fatigue—Doxorubicin—hematologic cancer	8.03e-06	9.86e-05	CcSEcCtD
Mometasone—NR3C1—Gene Expression—EZH2—hematologic cancer	7.97e-06	0.000412	CbGpPWpGaD
Mometasone—Pain—Doxorubicin—hematologic cancer	7.97e-06	9.78e-05	CcSEcCtD
Mometasone—Body temperature increased—Epirubicin—hematologic cancer	7.96e-06	9.77e-05	CcSEcCtD
Mometasone—Abdominal pain—Epirubicin—hematologic cancer	7.96e-06	9.77e-05	CcSEcCtD
Mometasone—CYP2C8—Metabolism—MTAP—hematologic cancer	7.86e-06	0.000406	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—PARP1—hematologic cancer	7.8e-06	0.000403	CbGpPWpGaD
Mometasone—Asthenia—Methotrexate—hematologic cancer	7.72e-06	9.48e-05	CcSEcCtD
Mometasone—Nausea—Prednisone—hematologic cancer	7.65e-06	9.39e-05	CcSEcCtD
Mometasone—Gastrointestinal pain—Doxorubicin—hematologic cancer	7.62e-06	9.36e-05	CcSEcCtD
Mometasone—Pruritus—Methotrexate—hematologic cancer	7.61e-06	9.35e-05	CcSEcCtD
Mometasone—Dexamethasone—ABCB1—hematologic cancer	7.54e-06	0.0044	CrCbGaD
Mometasone—NR3C1—Gene Expression—HDAC2—hematologic cancer	7.53e-06	0.000389	CbGpPWpGaD
Mometasone—Body temperature increased—Doxorubicin—hematologic cancer	7.37e-06	9.04e-05	CcSEcCtD
Mometasone—Abdominal pain—Doxorubicin—hematologic cancer	7.37e-06	9.04e-05	CcSEcCtD
Mometasone—Diarrhoea—Methotrexate—hematologic cancer	7.36e-06	9.04e-05	CcSEcCtD
Mometasone—Asthenia—Epirubicin—hematologic cancer	7.22e-06	8.87e-05	CcSEcCtD
Mometasone—Pruritus—Epirubicin—hematologic cancer	7.12e-06	8.75e-05	CcSEcCtD
Mometasone—CYP2C8—Metabolism—FHL2—hematologic cancer	7.01e-06	0.000362	CbGpPWpGaD
Mometasone—Diarrhoea—Epirubicin—hematologic cancer	6.89e-06	8.46e-05	CcSEcCtD
Mometasone—CYP2C8—Metabolism—AGRN—hematologic cancer	6.87e-06	0.000355	CbGpPWpGaD
Mometasone—Vomiting—Methotrexate—hematologic cancer	6.84e-06	8.4e-05	CcSEcCtD
Mometasone—Rash—Methotrexate—hematologic cancer	6.78e-06	8.33e-05	CcSEcCtD
Mometasone—Dermatitis—Methotrexate—hematologic cancer	6.78e-06	8.32e-05	CcSEcCtD
Mometasone—Headache—Methotrexate—hematologic cancer	6.74e-06	8.28e-05	CcSEcCtD
Mometasone—Asthenia—Doxorubicin—hematologic cancer	6.68e-06	8.21e-05	CcSEcCtD
Mometasone—Pruritus—Doxorubicin—hematologic cancer	6.59e-06	8.09e-05	CcSEcCtD
Mometasone—NR3C1—Gene Expression—AR—hematologic cancer	6.53e-06	0.000337	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—IDH2—hematologic cancer	6.51e-06	0.000336	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—HMMR—hematologic cancer	6.51e-06	0.000336	CbGpPWpGaD
Mometasone—Vomiting—Epirubicin—hematologic cancer	6.4e-06	7.86e-05	CcSEcCtD
Mometasone—Nausea—Methotrexate—hematologic cancer	6.39e-06	7.85e-05	CcSEcCtD
Mometasone—Diarrhoea—Doxorubicin—hematologic cancer	6.37e-06	7.83e-05	CcSEcCtD
Mometasone—Rash—Epirubicin—hematologic cancer	6.35e-06	7.8e-05	CcSEcCtD
Mometasone—Dermatitis—Epirubicin—hematologic cancer	6.34e-06	7.79e-05	CcSEcCtD
Mometasone—Headache—Epirubicin—hematologic cancer	6.31e-06	7.75e-05	CcSEcCtD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	6.14e-06	0.000317	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ARNTL—hematologic cancer	6.12e-06	0.000316	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—CDKN2B—hematologic cancer	6.01e-06	0.000311	CbGpPWpGaD
Mometasone—Nausea—Epirubicin—hematologic cancer	5.98e-06	7.34e-05	CcSEcCtD
Mometasone—CYP2C8—Metabolism—ACP5—hematologic cancer	5.96e-06	0.000308	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CA9—hematologic cancer	5.96e-06	0.000308	CbGpPWpGaD
Mometasone—Vomiting—Doxorubicin—hematologic cancer	5.92e-06	7.27e-05	CcSEcCtD
Mometasone—CYP2C8—Metabolism—NCOR2—hematologic cancer	5.88e-06	0.000304	CbGpPWpGaD
Mometasone—Rash—Doxorubicin—hematologic cancer	5.87e-06	7.21e-05	CcSEcCtD
Mometasone—Dermatitis—Doxorubicin—hematologic cancer	5.87e-06	7.21e-05	CcSEcCtD
Mometasone—Headache—Doxorubicin—hematologic cancer	5.84e-06	7.17e-05	CcSEcCtD
Mometasone—NR3C1—Gene Expression—NCOR1—hematologic cancer	5.7e-06	0.000295	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—IDH1—hematologic cancer	5.6e-06	0.000289	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GSTO1—hematologic cancer	5.54e-06	0.000286	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—TXN—hematologic cancer	5.54e-06	0.000286	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ABCC3—hematologic cancer	5.54e-06	0.000286	CbGpPWpGaD
Mometasone—Nausea—Doxorubicin—hematologic cancer	5.53e-06	6.8e-05	CcSEcCtD
Mometasone—CYP2C8—Metabolism—SPHK1—hematologic cancer	5.42e-06	0.00028	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—UGT1A1—hematologic cancer	5.21e-06	0.000269	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—SLC22A1—hematologic cancer	5.06e-06	0.000262	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CRABP1—hematologic cancer	5.06e-06	0.000262	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ALOX5—hematologic cancer	4.94e-06	0.000255	CbGpPWpGaD
Mometasone—NR3C1—Generic Transcription Pathway—MYC—hematologic cancer	4.84e-06	0.00025	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—NUP98—hematologic cancer	4.78e-06	0.000247	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ADCY7—hematologic cancer	4.64e-06	0.00024	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—NCOA3—hematologic cancer	4.64e-06	0.00024	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—NUP214—hematologic cancer	4.61e-06	0.000238	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—MAPK14—hematologic cancer	4.57e-06	0.000236	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	4.56e-06	0.000236	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—MTR—hematologic cancer	4.51e-06	0.000233	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ABCG2—hematologic cancer	4.51e-06	0.000233	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—ESR1—hematologic cancer	4.48e-06	0.000231	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ENO2—hematologic cancer	4.43e-06	0.000229	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—NOTCH1—hematologic cancer	4.33e-06	0.000224	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GSTT1—hematologic cancer	4.29e-06	0.000222	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	4.23e-06	0.000218	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—SDC1—hematologic cancer	4.2e-06	0.000217	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.01e-06	0.000207	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.96e-06	0.000204	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—CREBBP—hematologic cancer	3.93e-06	0.000203	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.79e-06	0.000196	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—NQO1—hematologic cancer	3.57e-06	0.000184	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CD44—hematologic cancer	3.57e-06	0.000184	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.49e-06	0.000181	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CYCS—hematologic cancer	3.38e-06	0.000174	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—HSP90AA1—hematologic cancer	3.36e-06	0.000173	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.02e-06	0.000156	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GSTP1—hematologic cancer	2.98e-06	0.000154	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.88e-06	0.000149	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ABCB1—hematologic cancer	2.82e-06	0.000146	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—NCOR1—hematologic cancer	2.74e-06	0.000141	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GSTM1—hematologic cancer	2.74e-06	0.000141	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—MTHFR—hematologic cancer	2.42e-06	0.000125	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—MAPK3—hematologic cancer	2.4e-06	0.000124	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—MYC—hematologic cancer	2.33e-06	0.00012	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.13e-06	0.00011	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PIK3CG—hematologic cancer	2.03e-06	0.000105	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CREBBP—hematologic cancer	1.88e-06	9.73e-05	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PIK3CD—hematologic cancer	1.79e-06	9.22e-05	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ALB—hematologic cancer	1.76e-06	9.11e-05	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PIK3R1—hematologic cancer	1.69e-06	8.71e-05	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—AKT1—hematologic cancer	1.62e-06	8.35e-05	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PIK3CB—hematologic cancer	1.56e-06	8.04e-05	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PTEN—hematologic cancer	1.34e-06	6.95e-05	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—EP300—hematologic cancer	1.28e-06	6.63e-05	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PIK3CA—hematologic cancer	9.49e-07	4.9e-05	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—AKT1—hematologic cancer	7.75e-07	4e-05	CbGpPWpGaD
